[成人体外膜氧合(ECMO)]。

J P Meinhardt, M Quintel
{"title":"[成人体外膜氧合(ECMO)]。","authors":"J P Meinhardt,&nbsp;M Quintel","doi":"10.1007/s00390-002-0343-2","DOIUrl":null,"url":null,"abstract":"<p><p>Despite ongoing discussions, ECMO (extracorporeal membrane oxygenation) has become an important part of treatment options in acute lung injury and ARDS (acute respiratory distress syndrome) even in adults. On the other hand, none of the two RCT (randomized controlled trial) studies resulted in reduced letality of the artificial lung therapy when compared to convention treatment. Both authors concluded, that ECMO is not recommended in ARDS. Meanwhile experience with ECMO in adults is extensive in various institutions worldwide, exceeding 1000 patients by the end of 2001. Growing experience and improved technical equipment reduce the rate of technical complications substantially. However, for different reasons ECMO incidence in adults is progressively decreasing in recent years.    Inclusion and exclusion criteria vary among different ECMO centers. Potential reversibility of lung injury and persisting life-threatening gas exchange disorder under maximal conventional therapy are commonly seen as requirements for ECMO therapy. ECMO criteria are Murray lung injury score >3.5 (chest x-ray, PaO<sub>2</sub>/FiO<sub>2</sub>-index, static compliance C<sub>stat</sub>, PEEP), Morel-classification >3 (chest x-ray, AaDO<sub>2</sub>/FiO<sub>2</sub>-index, C<sub>stat</sub>, PEEP), AaDO2 >600mmHg, intrapulmonal shunt Q<sub>S</sub>/Q<sub>T</sub> >30%, and increase in extravascular lung water >15 ml/kg bodyweight.    Commonly accepted absolute contraindications are (1) severely consuming disorders with poor prognosis, (2) CNS damage with poor prognosis, (3) advanced chronic lung disorders, and (4) progressive multiple organ failure. Relative contraindications are immunosuppresion, active bleeding, age over 60 years, and days on mechanical ventilation.    In our experience, early contact to an ECMO reference center can optimise early identification of patients which benefit from ECMO, as well as treatment and transportation modalities, and improves outcome. Due to high technical and personal requirements and decreasing incidence in the adult sector, ECMO should be limited to a small number of reference centers with substantial experience in extracorporeal circulation.</p>","PeriodicalId":92910,"journal":{"name":"Intensivmedizin + Notfallmedizin : Organ der Deutschen und der Osterreichischen Gesellschaft fur internistische Intensivmedizin, der Sektion Neurologie der DGIM und der Sektion Intensivmedizin im Berufsverband Deutscher Internisten e.V","volume":"39 8","pages":"694-706"},"PeriodicalIF":0.0000,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00390-002-0343-2","citationCount":"14","resultStr":"{\"title\":\"[Extracorporeal membrane oxygenation (ECMO) in adults].\",\"authors\":\"J P Meinhardt,&nbsp;M Quintel\",\"doi\":\"10.1007/s00390-002-0343-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Despite ongoing discussions, ECMO (extracorporeal membrane oxygenation) has become an important part of treatment options in acute lung injury and ARDS (acute respiratory distress syndrome) even in adults. On the other hand, none of the two RCT (randomized controlled trial) studies resulted in reduced letality of the artificial lung therapy when compared to convention treatment. Both authors concluded, that ECMO is not recommended in ARDS. Meanwhile experience with ECMO in adults is extensive in various institutions worldwide, exceeding 1000 patients by the end of 2001. Growing experience and improved technical equipment reduce the rate of technical complications substantially. However, for different reasons ECMO incidence in adults is progressively decreasing in recent years.    Inclusion and exclusion criteria vary among different ECMO centers. Potential reversibility of lung injury and persisting life-threatening gas exchange disorder under maximal conventional therapy are commonly seen as requirements for ECMO therapy. ECMO criteria are Murray lung injury score >3.5 (chest x-ray, PaO<sub>2</sub>/FiO<sub>2</sub>-index, static compliance C<sub>stat</sub>, PEEP), Morel-classification >3 (chest x-ray, AaDO<sub>2</sub>/FiO<sub>2</sub>-index, C<sub>stat</sub>, PEEP), AaDO2 >600mmHg, intrapulmonal shunt Q<sub>S</sub>/Q<sub>T</sub> >30%, and increase in extravascular lung water >15 ml/kg bodyweight.    Commonly accepted absolute contraindications are (1) severely consuming disorders with poor prognosis, (2) CNS damage with poor prognosis, (3) advanced chronic lung disorders, and (4) progressive multiple organ failure. Relative contraindications are immunosuppresion, active bleeding, age over 60 years, and days on mechanical ventilation.    In our experience, early contact to an ECMO reference center can optimise early identification of patients which benefit from ECMO, as well as treatment and transportation modalities, and improves outcome. Due to high technical and personal requirements and decreasing incidence in the adult sector, ECMO should be limited to a small number of reference centers with substantial experience in extracorporeal circulation.</p>\",\"PeriodicalId\":92910,\"journal\":{\"name\":\"Intensivmedizin + Notfallmedizin : Organ der Deutschen und der Osterreichischen Gesellschaft fur internistische Intensivmedizin, der Sektion Neurologie der DGIM und der Sektion Intensivmedizin im Berufsverband Deutscher Internisten e.V\",\"volume\":\"39 8\",\"pages\":\"694-706\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/s00390-002-0343-2\",\"citationCount\":\"14\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Intensivmedizin + Notfallmedizin : Organ der Deutschen und der Osterreichischen Gesellschaft fur internistische Intensivmedizin, der Sektion Neurologie der DGIM und der Sektion Intensivmedizin im Berufsverband Deutscher Internisten e.V\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s00390-002-0343-2\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intensivmedizin + Notfallmedizin : Organ der Deutschen und der Osterreichischen Gesellschaft fur internistische Intensivmedizin, der Sektion Neurologie der DGIM und der Sektion Intensivmedizin im Berufsverband Deutscher Internisten e.V","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00390-002-0343-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 14

摘要

尽管讨论仍在继续,ECMO(体外膜氧合)已成为成人急性肺损伤和ARDS(急性呼吸窘迫综合征)治疗方案的重要组成部分。另一方面,与常规治疗相比,两项RCT(随机对照试验)研究均未发现人工肺治疗的死亡率降低。两位作者得出结论,不建议在ARDS中使用ECMO。同时,成人体外膜肺氧合的经验在世界各地的各种机构中都很广泛,到2001年底已超过1000例。经验的增长和技术设备的改进大大降低了技术并发症的发生率。然而,由于不同的原因,近年来成人ECMO发病率逐渐下降。不同ECMO中心的纳入和排除标准不同。在最大限度的常规治疗下,肺损伤的潜在可逆性和持续危及生命的气体交换障碍通常被视为ECMO治疗的必要条件。ECMO标准为Murray肺损伤评分>3.5(胸片、PaO2/ fio2指数、静态顺应性Cstat、PEEP), morell分级>3(胸片、AaDO2/ fio2指数、Cstat、PEEP), AaDO2 >600mmHg,肺内分流QS/QT >30%,血管外肺水增加> 15ml /kg体重。目前公认的绝对禁忌症有:(1)预后不良的严重消耗障碍,(2)预后不良的中枢神经系统损害,(3)晚期慢性肺部疾病,(4)进行性多器官衰竭。相对禁忌症是免疫抑制,活动性出血,年龄超过60岁,机械通气天数。根据我们的经验,早期接触ECMO参考中心可以优化早期识别受益于ECMO的患者,以及治疗和运输方式,并改善结果。由于高技术和个人要求以及成人部门发病率下降,ECMO应限于少数具有丰富体外循环经验的参考中心。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Extracorporeal membrane oxygenation (ECMO) in adults].

Despite ongoing discussions, ECMO (extracorporeal membrane oxygenation) has become an important part of treatment options in acute lung injury and ARDS (acute respiratory distress syndrome) even in adults. On the other hand, none of the two RCT (randomized controlled trial) studies resulted in reduced letality of the artificial lung therapy when compared to convention treatment. Both authors concluded, that ECMO is not recommended in ARDS. Meanwhile experience with ECMO in adults is extensive in various institutions worldwide, exceeding 1000 patients by the end of 2001. Growing experience and improved technical equipment reduce the rate of technical complications substantially. However, for different reasons ECMO incidence in adults is progressively decreasing in recent years.    Inclusion and exclusion criteria vary among different ECMO centers. Potential reversibility of lung injury and persisting life-threatening gas exchange disorder under maximal conventional therapy are commonly seen as requirements for ECMO therapy. ECMO criteria are Murray lung injury score >3.5 (chest x-ray, PaO2/FiO2-index, static compliance Cstat, PEEP), Morel-classification >3 (chest x-ray, AaDO2/FiO2-index, Cstat, PEEP), AaDO2 >600mmHg, intrapulmonal shunt QS/QT >30%, and increase in extravascular lung water >15 ml/kg bodyweight.    Commonly accepted absolute contraindications are (1) severely consuming disorders with poor prognosis, (2) CNS damage with poor prognosis, (3) advanced chronic lung disorders, and (4) progressive multiple organ failure. Relative contraindications are immunosuppresion, active bleeding, age over 60 years, and days on mechanical ventilation.    In our experience, early contact to an ECMO reference center can optimise early identification of patients which benefit from ECMO, as well as treatment and transportation modalities, and improves outcome. Due to high technical and personal requirements and decreasing incidence in the adult sector, ECMO should be limited to a small number of reference centers with substantial experience in extracorporeal circulation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信